Spectranetics is a developer of single-use medical technology for surgeries, with a focus on cardiovascular health. Their products include lead management and peripheral and coronary intervention tools, such as scoring balloon technology and laser atherectomy. The company is dedicated to product innovation and offers expert tools, training, and support to help manage every cardiac lead, modify all plaque, and eradicate restenosis and amputation. Recently acquired by Philips, Spectranetics continues to investigate new ways to meet the demands of minimally invasive cardiac lead removal and vascular intervention procedures.